Previous Close | 7.78 |
Open | 7.60 |
Bid | 7.37 x 800 |
Ask | 7.58 x 1400 |
Day's Range | 7.36 - 7.82 |
52 Week Range | 3.48 - 35.94 |
Volume | |
Avg. Volume | 3,356,703 |
Market Cap | 1.079B |
Beta (5Y Monthly) | 2.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.46 |
Earnings Date | Nov 02, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 16.88 |
Subscribe to Yahoo Finance Plus to view Fair Value for TGTX
The mean of analysts' price targets for TG Therapeutics (TGTX) points to a 192.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
This month, we saw the TG Therapeutics, Inc. ( NASDAQ:TGTX ) up an impressive 53%. But that doesn't change the fact...
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 38.78% and 590.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?